Rapid one-step biotinylation of biological and non-biological surfaces by Henry, Stephen et al.
1SCIENTIFIC REPORTS |  (2018) 8:2845  | DOI:10.1038/s41598-018-21186-3
www.nature.com/scientificreports
Rapid one-step biotinylation of 
biological and non-biological 
surfaces
Stephen Henry1, Eleanor Williams1, Katie Barr1, Elena Korchagina2, Alexandr Tuzikov2, 
Natalia Ilyushina3, Sidahmed A. Abayzeed4, Kevin F. Webb4 & Nicolai Bovin1,2
We describe a rapid one-step method to biotinylate virtually any biological or non-biological surface. 
Contacting a solution of biotin-spacer-lipid constructs with a surface will form a coating within seconds 
on non-biological surfaces or within minutes on most biological membranes including membrane 
viruses. The resultant biotinylated surface can then be used to interact with avidinylated conjugates, 
beads, vesicles, surfaces or cells.
Biotinylation has for many years been used as important tool for attaching a variety of molecules to surfaces 
including cells, via the strong affinity association constant of 1015 M−1 with avidin. The attachment of biotin 
to non-biological surfaces generally requires multistep functionalisation of the surface while the attachment of 
biotin to cells and viruses usually involves covalently attaching biotin to random proteins at the cell surface1. As 
most cells and viruses are relatively fragile, exposure to chemical modification has the risk of affecting vitality, 
functionality and can modify antigenicity2.
Recently a series of water-dispersible amphipathic constructs known as function-spacer-lipids (FSLs) 
have been described for labelling cells, membrane viruses, and solid surfaces with a range of biological and 
non-biological markers under physiological conditions3,4. The basic structure of the FSL construct is typically 
a hydrophilic functional head; a biologically inert hydrophilic spacer which assists the construct to disperse in 
water and spaces the functional head away from the surface; and a lipid tail which makes the construct amphip-
athic and drives the spontaneous self-assembly on surfaces and insertion into lipid-based membranes3. Here we 
describe application of FSLs where the functional head is biotin. Terminology guidelines have been adopted (see 
Supplementary Note 3).
Results
Synthesis. FSL-biotin based on a negatively charged carboxymethylglycine (CMG(2)) spacer with a DOPE 
lipid tail (FSdL-biotin) (Fig. 1) is commercially available (Sigma-Aldrich, cat #F9182), but its performance char-
acteristics are largely unreported5–9. For this evaluation we also synthesized several variants including two con-
structs with synthetic ceramide lipid tails (FScL-biotin), identical to the natural C18:0 ceramide, and one with a 
ceramide mimetic 2-(tetradecyl)hexadecanol (FSc1L-biotin). A construct with cholesterol (FSsL-biotin) was also 
synthesized according to published procedures and new synthesis developments5 (Supplementary Notes 1a–d). 
In addition, a variation with an uncharged O-methylated CMG(2) spacer was also prepared (Supplementary 
Note 1a). For the uses described in this paper all FSL-biotin constructs (Fig. 1a–d) performed well, except the 
uncharged spacer construct which had limited solubility in water and aqueous buffers.
Biotinylation of cells. There are many methodological variations that can be tailored and used to prepare 
kodecytes (i.e. cells modified with Kode constructs), each with subtle differences in the rate and amount of FSL 
construct that will insert into the cell membrane. Provided the same procedure and variables are used for all cells 
of a specific type and quality, the experimental results will be comparable between kodecytes prepared on differ-
ent occasions. Typically assay controls are prepared at the same time as kodecytes using the same cells except they 
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are incubated either with the FSL diluent (without FSLs) and ideally also with a benign FSL (of similar structure 
but with no activity).
Biotinylation of intact cellular biological membranes with FSL-biotin to create biotin-kodecytes involved 
contacting a suspension of cells with a buffer containing FSL-biotin and incubating at 37 °C for at least 30 min. 
Concentration dependent modification occurred with dilutions of FSL-biotin over the range of 0.5–50 µM and 
the resultant biotinylation was easily detected with fluorescently labelled avidin (Fig. 2). Biotin-kodecytes were 
able to maintain their biotin labels for time-periods related to their rate of membrane activity (vitality) and the 
environment in which they were exposed, usually for at least 24 h or more8,9. Extensive washing did not effect on 
the level of labelling on biotin kodecytes. Non-viable and dead cells are strongly labelled and retain their label 
longer than viable cells, thus indirectly providing a simple method of determining viability and separating viable 
cells from non-viable cells.
All forms of avidin were able to effectively convert biotin-kodecytes into avidin-kodecytes however there 
were sometimes different performance characteristics depending on the innate reactivity of the avidin type with 
the surfaces used. Modification of membrane viruses with FSL constructs to create so-called kodevirions10 was 
achieved by contacting a suspension of virus particles with a buffer containing FSL-biotin and incubating at 
37 °C for 30–60 min7. Biotin kodevirions (Fig. 2f) were functional and able to maintain their biotin labels for 
time-periods related to their environment. Moreover, no differences were observed in growth rates between bio-
tin kodevirions and their respective unlabeled counterparts at any of the post-infection time points in vitro, 
indicating than non-destructive non-covalent modification of viral membranes with FSL constructs do not affect 
viral replication fitness7. General recommendations for FSL constructs handling see in Supplementary Note 4.
Coating of surfaces. The ability of FSL-biotin to label non-biological surfaces was evaluated by applying 
FSL-biotin constructs to a large variety of non-corroding surfaces as previously done with glycan-FSLs3. It was 
found that all tested non-biological surfaces were modified with FSdL-biotin, including materials such as plastics, 
paper, rubbers, metals, and composites, whether in a planar, spherical or fibrous/weave format including nanofi-
bres (Supplementary Note 2).
The primary surface detection method used was an enzyme assay with alkaline phosphatase labelled streptavi-
din (Fig. 3a). Alternatively, reactions could be visualised with biotinylated cells captured via avidin microspheres 
(Fig. 3c) or planar surfaces (Fig. 3e), or by an enzyme immunoassay (EIA), where a captured protein (via 
streptavidin) is visualised with specific antibodies and secondary reactions (Fig. 3b), or with fluorophore labelled 
avidin (Fig. 3d). Not all variations of avidin11 (e.g. avidin, neutravidin, streptavidin) are equally suitable for all 
surfaces and kodecyte combinations and optimization is required.
Factors influencing FSL surface coating and its stability were also evaluated primarily on stainless steel, poly-
ester and paper surfaces (Fig. 3a), with results almost identical to those obtained with the glycan FSL constructs5. 
Composition of the FSL lipid tail, concentration (1–50 µM), contact time and method of application (inkjet print-
ing, painting or immersion) were all found to subtly or significantly influence the quality and stability of the 
coating on different surfaces. The time required for an FSL-biotin construct to label a non-biological surface 
could be as short as 5 seconds, although generic methodology used 10–30 min. Modified surfaces did not require 
drying before use, but were usually air-dried, and were stable unprotected for at least 8 months at ambient tem-
perature. FSL-biotin surfaces when contacted with water, saline or serum were stable for at least 12 hours, but the 
Figure 1. Chemical structures of FSL-biotin constructs with lipid variations. (a) FSdL: 1,2-O-dioleoyl-sn-glycero-
3-phosphatidylethanolamine. (b) FScL: ceramide (synthesized chemically, identical to natural one). (c) FSc1L: 
ceramide mimetic, 2-(tetradecyl)hexadecanol. (d) FSsL: cholesterol. In order to describe the large variety and 
combinations of FSL constructs and the biological and non-biological surfaces and membranes they can modify.
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FSL-biotin construct could be removed with detergents with concentrations >1% or with solvents such as 70% 
methanol. In general, all surfaces were able to be modified by FSL-biotin adequately for most analyses, although 
some materials had better labelling and stability performance characteristics than others. The kinetics of the coat-
ing, as well as the formed layers stability for washing were evaluated using the SPR method (see Supplementary 
Note 5).
Discussion
FSL-biotin is able to efficiently label almost all non-biological surfaces with a biotin coating that is sufficiently 
robust to immobilise proteins and cells (under gentle shear conditions). In addition, mammalian cells can be 
effectively labelled in a dose dependent manner with biotin, and the resultant biotin-kodecytes are able to interact 
(via avidin) with biotinylated proteins, non-biological surfaces and other cells. Similarly, membrane virions and 
liposomes were effectively labelled. There is no evidence of a loss in functionality or vitality of biotin-kodecytes8,9 
or kodevirions7 and they can be used both for in vitro and in vivo studies. For general use the FSL-biotin based 
on the DOPE lipid tail (Fig. 1a) performed well, and unless a specific need exists there was no significant advan-
tage of using other lipid variations (e.g. sterol or ceramide). Nevertheless, we expect that synthesised versions 
(Fig. 1b–d) will be required for design of membranes where presentation of the FSL (head/tail ratio) is important, 
and when the type of lipid tail affects the locating of the construct within a lipid membrane. FSL-biotin labelling 
is convenient and harmless method for temporary biotinylation of biological surfaces, and a rapid comprehensive 
method for temporary biotinylation of non-biological surfaces. It can be used either alone or with other existing 
methods. FSL-biotin together with other non-biotin FSLs, have the potential to expand research opportunities.
Methods
Biotin-kodecytes. The following method, together with cell-specific caveats, can be tailored to fit with any 
living or dead cell (including those modified with glutaraldehyde fixation before or after koding).
•	 Prepare an FSL-biotin stock solution in a lipid and detergent free buffer (e.g. PBS or serum-free cell culture 
media) at a concentration of 1 mM.
Figure 2. FSL-biotinylation of biologicals with FSLs, examples. Generic methods for (a–f) are as described 
in Methods. (a) Fluorescent image of human red cells incubated in FSc1L-biotin (5 µM) and visualised with 
NeutravidinDyLight488 (100 µg/mL), (400× magnification). (b) Light image of motile human spermatozoa 
incubated with FSdL-biotin (50 µM) then immobilized with Dynabeads M-280 Streptavidin (2.8 µm) (400× 
magnification). (c) Confocal image of murine embryo with zona pellucida removed, incubated with FSdL-
biotin (50 µM) and visualized with Avidin Alexa Fluor488 (2 µg/mL) then fixed in 4% formaldehyde. (d) 
Confocal image of zona pellucida prepared as in (c). (e) Fluorescent image of epithelial RL95 cells incubated 
with FSdL-biotin (250 µM) and visualized with Avidin Alexa Fluor488 (100 µg/mL) (200× magnification). (f) 
Fluorescent image of MDCK cells infected (for 4 h at 37 °C) with A/California/04/09 H1N1 influenza virus 
labelled with 25 µM FSdL-biotin for 1 h. Left panel, infected cells; right panel, mock-infected cells. Cells were 
fixed with 4% paraformaldehyde and stained with Alexa Fluor488 Streptavidin. Viruses are stained in green; 
nuclei—in blue (DAPI). Viruses are detected both on cell surface and inside cells (400× magnification).
www.nature.com/scientificreports/
4SCIENTIFIC REPORTS |  (2018) 8:2845  | DOI:10.1038/s41598-018-21186-3
•	 It can be prepared in water, but may degrade upon 4 °C storage, and should be stored frozen as aliquots. 
Repeated freeze-thawing appears to have no effect on construct stability.
•	 Prepare the working FSL solution by diluting stock FSL-biotin solution in buffer (as above). The optimal dilu-
tion used will need to be experimentally determined for each particular use, but will usually be in the range 
of 1–100 μM (2–200 μg/mL), with typical concentrations for FSL-biotin intended for biological membranes 
being in the range of 10–50 μM. If necessary, other non-biotin FSL constructs can also be added to the same 
solution for simultaneous insertion.
•	 Next, prepare the cells intended for modification into kodecytes. Wash them free of serum lipids (e.g. at least 
2 × in PBS) and make as a cell suspension of any known concentration in the same media as the FSL solution 
has been prepared. Typically, 50–80% cell suspensions are used as they can be delivered accurately by pipette; 
however a single cell can be modified if transferred to a solution of FSL constructs.
•	 Place one part of FSL solution into a test tube. Add up to one part of cell suspension to the one part of FSL 
solution. Mix and incubate, time and temperature will be that which is compatible with the cell being mod-
ified and can range from 4–40 °C and from 10 min up to several days. Typically, mammalian cells will be 
adequately modified after 30–120 min at 37 °C. The lower the temperature, the longer that may be required 
to achieve the same level of cell surface modification achieved at a higher temperature. Note: FSL constructs 
may become internalised by some cell types over time. Once the incubation is complete, transfer the newly 
formed kodecytes to an FSL free solution. There is no requirement to wash (or transfer) the kodecytes if low 
concentrations of FSL were used, but this is usually done to ensure no free FSLs are present in the solution 
phase, and to stop the reaction proceeding during storage if short incubation times are used. The solution 
receiving the kodecytes can be serum or contain lipids, however stability of the membrane bound FSLs may 
be reduced.
Avidin kodecytes are prepared from biotin-kodecytes by adding avidin in excess. The three common forms 
of avidin (egg avidin, streptavidin & neutravidin, collectively termed avidin) routinely available can all be used. 
The level of avidin on the kodecyte is directly controlled by the amount of FSL-biotin on the biotin-kodecyte and 
therefore needs not be directly described. Avidin-kodecytes will not self-aggregate provided all (most) biotin 
residues are saturated with avidin, this can be achieved by using avidin in excess.
Figure 3. FSL-biotinylation of non-biological surfaces, examples. Generic methodologies are as described 
in Methods. (a) Inkjet printing of three different FSL-biotin constructs (Fig. 1) on three different materials; 
paper (left), polyester (middle) and 316 stainless steel (right), visualised by enzyme assay. (b) Immobilisation 
via streptavidin of a biotinylated HLA protein onto inkjet printed FSL biotin characters on paper, visualised by 
enzyme immunoassay, with negative reactions (lower wells) in the absence of biotinylated HLA protein. (c) Two 
focal planes of red cell biotin kodecytes captured onto biotin koded polycarbonate microspheres (20 µm) via 
streptavidin bridging, light microscopy (1000× magnification). (d) Biotin koded polycarbonate microspheres 
(20 µm) visualised by Avidin AlexaFluor®488 fluorescent microscopy (200× magnification). (e) FSdL-biotin 
printed on polyester visualised by capture of red cell biotin kodecytes via neutravidin bridging, left (30× 
magnification) and right (2000× magnification), SEM.
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•	 Prepare biotin-kodecytes (typically < 50 μM) and wash them once into the same buffer as is intended to prepare 
the avidin solution. Dilute the biotin-kodecytes to a <10% cell suspension. Prepare a solution of 7.5 μM avidin 
in PBS or other biocompatible (serum/detergent free) media. Add one part of avidin solution to one part of 
biotin-kodecytes, mix and incubate for 30 min at RT. Wash away unbound avidin (by centrifugation) with PBS.
Koded surfaces. Almost any surface can be modified with FSL constructs and although the methods of 
application maybe different, all are essentially the same, and only involve contacting a solution of FSL with a 
surface. If the application of the FSL is to a non-biological surface, biologically incompatible solvent systems may 
be used (in ethanol, methanol and isopropanol:water mixes of less than 70%). If water (without salts) is used, the 
construct solution should be used within 24 h to reduce the risk of FSL degradation3.
Typical concentrations for FSL-biotin are in the range of 0.01–50 μM. If layering occurs, then upper layers may 
be more easily lost (e.g. by washing) to the environment than the primary layer in contact with the surface. It is for 
this reason that it is recommended the koded surfaces be washed prior to use (e.g. prior to reacting with avidin). 
Additionally, each different method of application, concentration of FSL, mixtures of FSLs, solvent surface tension 
and ability to wet the surface, air-solvent interfaces (when dipping), rate of drying (or not drying) and other fac-
tors may affect assembly of the FSL on a particular surface and can create edge layering artefacts. The subsequent 
stability/retention of an FSL surface coating may thus depend on all the above factors and the time, temperature 
and the environment the koded surface is exposed6,7.
Prepare an FSL-biotin solution at an appropriate concentration (typically 50 μM or less is suitable for most 
applications including inkjet printing). Most surfaces require no prior preparation unless they have an unbound 
coating on them, such as an oil film (which may be present on metal sheeting) or particulates. If required, wash 
the surface clean with an appropriate solvent. Drying of the surface prior to application is not necessary.
Application of the FSL to the surface can be by one of several of the following techniques:
Dipping/immersion. Prepare a vessel containing a solution of FSL and place the surface (planar or microspheres) 
to be modified into the solution. After a short incubation, or immediately remove the surface. A washing step 
(before or after drying) may be undertaken. Either allow the surface to dry or transfer to a new buffer for storage.
Brushing/spotting/spraying/drying. Use a paintbrush, dropper, pipette or spray unit to apply the FSL to a surface 
(including the wells of a microplate). Either allow the surface to dry or transfer to a new buffer for storage. A 
washing step may be undertaken if desired.
Inkjet printing. A piezoelectric inkjet printer (e.g. Epson Stylus T21) can be used to print FSLs12. Constructs 
are also compatible with thermal printers. Sponge-less, refillable cartridges are used, and can be volume capacity 
reduced by partially filling with an inert resin. Cartridges are cleaned with 70% ethanol and deionised water 
before filling with FSL. Solutions containing 50 μM of FSL-biotin were prepared for printing in PBS or water. 
Bromophenol blue dye can be included in the solution at a concentration of 0.5% to enable printed area to be 
observed—this dye being lost during subsequently washing procedures. The colour management of the printer 
was adjusted to print the desired solution from the correct cartridge, and prevent the mixing of inks (different 
FSL’s) in other cartridges. After inserting the FSL-loaded cartridge the printer was primed by printing solid blocks 
of colour, which removed air bubbles and primed the printing solution through to the print head. If the mem-
brane to be printed was too fragile to allow passage through an inkjet printer (e.g. nano fibres, gold sheet), it could 
be stabilised on a support surface or captured onto a single side of a document laminating film (backing)12. After 
printing the koded surfaces could be used immediately or stored at RT for many months. After printing the inkjet 
print-head can be washed with water and 70% methanol:water, or preferably replaced or restricted to use with a 
single type of FSL.
Avidin-koded surfaces. Similarly, to creating avidin-kodecytes a surface can be easily avidinylated by sim-
ply flooding the biotin koded surface with avidin. Essentially the surface is first prepared with an FSL-biotin 
coating (as above), washed 2–3 times with water or PBS to remove/reduce any layering of FSL’s then reacted with 
an avidin solution. If using microspheres, avidin should be in excess to reduce the possibility of aggregation due 
to crosslinking. Modified surfaces can be stored in PBS at 4 °C for at least several months.
Capturing biotinylated proteins onto avidin-koded surfaces. Biotin + avidin koded surfaces (planar, 
fibrous or microspheres) can be used to capture biotinylated proteins (e.g. Fig. 3d). Avidin koded surfaces are 
first prepared as above. After (optional) blocking for 30 min with 2% BSA in PBS, biotinylated protein (includ-
ing biotinylated IgG) appropriately diluted in 2% BSA, is flooded onto the surface and allowed to react with the 
FSL-biotin + avidin complex for 30 min at RT. The surface is then washed 6 times with PBS and is ready for vis-
ualisation with antibodies in an EIA assay or reacting with ligands or cells.
Capturing kodecytes (or koded microspheres) onto biotin/avidin koded surfaces. To capture 
biotin-kodecytes (or biotin microspheres) onto avidin + biotin koded surfaces or alternatively to capture avi-
din + biotin-kodecytes (or microspheres) onto biotin koded surfaces (e.g. Figs 2b and 3b,c). Not all kodecytes 
or koded microspheres will interact with koded surfaces, and variations in interactions and binding may be 
observed depending on experimental conditions.
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Detection of FSL-biotin with labelled avidin (enzyme/fluorophore). The detection of FSL-biotin on 
koded surfaces and/or kodecytes can be via the use of alkaline phosphatase labelled avidin (usually streptavidin) 
precipitation of the chromogenic substrate NBT/BCIP (e.g. Fig. 3a) or fluorophore labelled avidin (e.g. Fig. 3d).
Precipitating chromogenic substrate. Biotin koded surfaces are blocked with 3% BSA-PBS for 30 min then 
decanted. Onto each surface was flooded with streptavidin alkaline phosphatase (Sigma S2890) appropriately 
diluted in BSA-PBS and then incubated for 30 min at RT. BSA-PBS used as a negative reagent control. Following 
incubation plates were washed 6 times by immersion for 20 sec in beakers of fresh PBS. Precipitating chromog-
enic substrate (NBT/BCIP stock solution, 18.8 mg/mL nitro blue tetrazolium chloride and 9.4 mg/mL 5-bromo-
4-chloro-3-indolyl phosphate toluidine salt in 67% DMSO (v/v); Roche, Mannheim, Germany) was diluted 1:50 
in substrate buffer (100 mM Tris, 100 mM NaCl, 50 mM MgCl2, pH 9.5) and the surface was flooded with sub-
strate. Surfaces were incubated at RT for 2–10 min and the reaction was stopped by rinsing with water. Developed 
plates were allowed to air dry and can be stored indefinitely unprotected at RT. The rare limitation of this tech-
nique is false negative results may occur if final precipitate is unable to be retained at the surface.
Fluorescence. Biotin koded surfaces (optionally blocked with 2% BSA) are flooded with streptavidin fluorophore 
(AlexaFluor 488) appropriately diluted (usually 0.1 mg/ml) in PBS and then incubated for 30 min at RT. Following 
incubation, the surfaces were washed 3 times with PBS before viewing under UV.
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